Stratos Wealth Partners’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$128K Buy
60,750
+9,200
+18% +$19.4K ﹤0.01% 1372
2025
Q1
$62.9K Hold
51,550
﹤0.01% 1335
2024
Q4
$66.5K Buy
51,550
+11,100
+27% +$14.3K ﹤0.01% 1416
2024
Q3
$111K Hold
40,450
﹤0.01% 1385
2024
Q2
$91.4K Hold
40,450
﹤0.01% 1326
2024
Q1
$96.7K Hold
40,450
﹤0.01% 1337
2023
Q4
$67.1K Hold
40,450
﹤0.01% 1339
2023
Q3
$77.7K Hold
40,450
﹤0.01% 1239
2023
Q2
$58.2K Hold
40,450
﹤0.01% 1169
2023
Q1
$84.9K Sell
40,450
-500
-1% -$1.05K ﹤0.01% 1093
2022
Q4
$46.3K Hold
40,950
﹤0.01% 1117
2022
Q3
$67K Hold
40,950
﹤0.01% 1088
2022
Q2
$54K Hold
40,950
﹤0.01% 1159
2022
Q1
$66K Hold
40,950
﹤0.01% 1233
2021
Q4
$85K Hold
40,950
﹤0.01% 1222
2021
Q3
$159K Hold
40,950
﹤0.01% 1121
2021
Q2
$131K Hold
40,950
﹤0.01% 1145
2021
Q1
$89K Hold
40,950
﹤0.01% 1091
2020
Q4
$92K Sell
40,950
-500
-1% -$1.12K ﹤0.01% 1047
2020
Q3
$111K Hold
41,450
﹤0.01% 965
2020
Q2
$127K Hold
41,450
﹤0.01% 936
2020
Q1
$81K Hold
41,450
﹤0.01% 882
2019
Q4
$119K Hold
41,450
﹤0.01% 942
2019
Q3
$152K Hold
41,450
0.01% 902
2019
Q2
$172K Buy
41,450
+500
+1% +$2.08K 0.01% 892
2019
Q1
$209K Hold
40,950
0.01% 851
2018
Q4
$140K Buy
40,950
+12,796
+45% +$43.7K 0.01% 818
2018
Q3
$169K Hold
28,154
0.01% 909
2018
Q2
$179K Hold
28,154
0.01% 912
2018
Q1
$133K Hold
28,154
0.01% 1057
2017
Q4
$94K Hold
28,154
﹤0.01% 1218
2017
Q3
$60K Buy
28,154
+4,000
+17% +$8.53K ﹤0.01% 904
2017
Q2
$59K Hold
24,154
﹤0.01% 814
2017
Q1
$56K Hold
24,154
﹤0.01% 781
2016
Q4
$24K Hold
24,154
﹤0.01% 711
2016
Q3
$27K Buy
24,154
+5,754
+31% +$6.43K ﹤0.01% 674
2016
Q2
$27K Hold
18,400
﹤0.01% 619
2016
Q1
$26K Hold
18,400
﹤0.01% 571
2015
Q4
$30K Buy
18,400
+8,400
+84% +$13.7K ﹤0.01% 576
2015
Q3
$23K Sell
10,000
-1,100
-10% -$2.53K ﹤0.01% 537
2015
Q2
$30K Sell
11,100
-8,000
-42% -$21.6K ﹤0.01% 519
2015
Q1
$66K Hold
19,100
0.01% 603
2014
Q4
$66K Hold
19,100
0.01% 495
2014
Q3
$96K Buy
19,100
+6,200
+48% +$31.2K 0.02% 303
2014
Q2
$180K Buy
+12,900
New +$180K 0.06% 295